MedTrace Logo

Skin Tolerance of Medical Devices for Diabetes Monitoring and Treatment in Children With Type 1 Diabetes

NCT05932953 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2023-07-06

No results posted yet for this study

Summary

In view of the emergence over the last few years of adverse skin reactions caused by diabetes monitoring and treatment devices, which have become essential to the optimal management of these patients, it is necessary to determine the real prevalence of these side effects.

Here the investigators performed a prospective study about prevalence of skin reactions in a group of children with type 1 diabetes.

Conditions

  • Cutaneous Allergy
  • Diabetes Mellitus, Type 1
  • Atopic Disorders

Interventions

OTHER

questionary

questionary about cutaneous tolerance

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • Emeline RENARD, PhD · CHRU Nancy

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-15
Primary Completion
2023-10-01
Completion
2023-11-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05932953 on ClinicalTrials.gov